메뉴 건너뛰기




Volumn 10, Issue 5, 2006, Pages 653-663

Targeting the CB2 receptor for immune modulation

Author keywords

9 tetrahydrocannabinol; Cannabinoid CB2 receptor; Chemotaxis; Experimental autoimmune encephalomyelitis; Inverse agonist

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; AJULEMIC ACID; ANANDAMIDE; ANTIINFLAMMATORY AGENT; CANNABIDIOL; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AFFECTING AGENT; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; DRONABINOL; IMMUNOMODULATING AGENT; JTE 907; RIMONABANT; SCH 036; SCH 336; SULFONE DERIVATIVE; UNCLASSIFIED DRUG; CANNABINOID;

EID: 33749261955     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.10.5.653     Document Type: Review
Times cited : (59)

References (71)
  • 1
    • 32944482013 scopus 로고    scopus 로고
    • Plant, synthetic, and endogenous cannabinoids in medicine
    • DI MARZO VD, PETROCELLIS LD: Plant, synthetic, and endogenous cannabinoids in medicine. Ann. Rev. Med. (2006) 57:553-574.
    • (2006) Ann. Rev. Med. , vol.57 , pp. 553-574
    • Di Marzo, V.D.1    Petrocellis, L.D.2
  • 2
  • 3
    • 0025325535 scopus 로고
    • Structure of a cannabinoid receptor and functional expression of the cloned cDNA
    • MATSUDA LA, LOLAIT SJ, BROWNSTEIN MJ, YOUNG AC, BONNER TI: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (1990) 346(6284):561-564.
    • (1990) Nature , vol.346 , Issue.6284 , pp. 561-564
    • Matsuda, L.A.1    Lolait, S.J.2    Brownstein, M.J.3    Young, A.C.4    Bonner, T.I.5
  • 4
    • 33646571242 scopus 로고    scopus 로고
    • Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain
    • CRISTINO L, DE PETROCELLIS L, PRYCE G, BAKER D, GUGLIELMOTTI V, DI MARZO V: Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience (2006) 139(4):1405-1415.
    • (2006) Neuroscience , vol.139 , Issue.4 , pp. 1405-1415
    • Cristino, L.1    De Petrocellis, L.2    Pryce, G.3    Baker, D.4    Guglielmotti, V.5    Di Marzo, V.6
  • 5
    • 0027515373 scopus 로고
    • Molecular characterization of a peripheral receptor for cannabinoids
    • MUNRO S, THOMAS KL, ABU-SHAAR M: Molecular characterization of a peripheral receptor for cannabinoids. Nature (1993) 365:61-65.
    • (1993) Nature , vol.365 , pp. 61-65
    • Munro, S.1    Thomas, K.L.2    Abu-Shaar, M.3
  • 6
    • 32844465920 scopus 로고    scopus 로고
    • 2 receptors: Immunohistochemical localization in rat brain
    • 2 receptors: immunohistochemical localization in rat brain. Brain Res. (2006) 1071(1):10-23.
    • (2006) Brain Res. , vol.1071 , Issue.1 , pp. 10-23
    • Gong, J.P.1    Onaivi, E.S.2    Ishiguro, H.3
  • 7
    • 33645106816 scopus 로고    scopus 로고
    • 2 receptor-mediated antihyperalgesia: Possible direct involvement of neural mechanisms
    • 2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur. J. Neurosci. (2006) 23(6):1530-1538.
    • (2006) Eur. J. Neurosci. , vol.23 , Issue.6 , pp. 1530-1538
    • Beltramo, M.1    Bernardini, N.2    Bertorelli, R.3
  • 8
    • 30344476972 scopus 로고    scopus 로고
    • In silico parent searching reveals a new cannabinoid receptor
    • BAKER D, PRYCE G, DAVIES WL, HILEY CR: In silico parent searching reveals a new cannabinoid receptor. Trends Pharmacol. Sci. (2006) 27(1):1-4.
    • (2006) Trends Pharmacol. Sci. , vol.27 , Issue.1 , pp. 1-4
    • Baker, D.1    Pryce, G.2    Davies, W.L.3    Hiley, C.R.4
  • 9
    • 33646814424 scopus 로고    scopus 로고
    • Cannabinoid receptors and endocannabinoids: Evidence for new players
    • MACKIE K, STELLA N: Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J. (2006) 8:E298-E306.
    • (2006) AAPS J. , vol.8
    • Mackie, K.1    Stella, N.2
  • 10
    • 0346350327 scopus 로고    scopus 로고
    • The cannabinoid system and immune modulation
    • KLEIN TW, NEWTON C, LARSEN K et al.: The cannabinoid system and immune modulation. J. Leukoc. Biol. (2003) 74:486-496.
    • (2003) J. Leukoc. Biol. , vol.74 , pp. 486-496
    • Klein, T.W.1    Newton, C.2    Larsen, K.3
  • 11
    • 0034685707 scopus 로고    scopus 로고
    • Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor
    • BUCKLEY NE, MCCOY KL, MEZEY E et al.: Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol. (2000) 396:141-149.
    • (2000) Eur. J. Pharmacol. , vol.396 , pp. 141-149
    • Buckley, N.E.1    McCoy, K.L.2    Mezey, E.3
  • 12
    • 22044449933 scopus 로고    scopus 로고
    • 2 receptor negatively regulates IL-12p40 production in murine macrophages: Role of IL-10 and ERK1/2 kinase signaling
    • 2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling. Br. J. Pharmacol. (2005) 145(4):441-448.
    • (2005) Br. J. Pharmacol. , vol.145 , Issue.4 , pp. 441-448
    • Correa, F.1    Mestre, L.2    Docagne, F.3    Guaza, C.4
  • 13
    • 0037255987 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of cannabinoids
    • GROTENHERMEN F: Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. (2003) 42:327-360.
    • (2003) Clin. Pharmacokinet. , vol.42 , pp. 327-360
    • Grotenhermen, F.1
  • 15
    • 33745280979 scopus 로고    scopus 로고
    • Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator activated receptor{gamma} independently of cannabinoid receptors 1 and 2
    • (Epub ahead of print)
    • ROCKWELL CE, SNIDER NT, THOMPSON JT, VANDEN HEUVEL JP, KAMINSKI NE: Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator activated receptor{gamma} independently of cannabinoid receptors 1 and 2. Mol. Pharmacol. (2006) (Epub ahead of print).
    • (2006) Mol. Pharmacol.
    • Rockwell, C.E.1    Snider, N.T.2    Thompson, J.T.3    Vanden Heuvel, J.P.4    Kaminski, N.E.5
  • 16
    • 27744460312 scopus 로고    scopus 로고
    • The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner
    • CURRAN NM, GRIFFIN BD, O'TOOLE D, BRADY KJ, FITZGERALD SN, MOYNAGH PN: The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner. J. Biol. Chem. (2005) 280(43):35797-35806.
    • (2005) J. Biol. Chem. , vol.280 , Issue.43 , pp. 35797-35806
    • Curran, N.M.1    Griffin, B.D.2    O'Toole, D.3    Brady, K.J.4    Fitzgerald, S.N.5    Moynagh, P.N.6
  • 17
    • 0033614984 scopus 로고    scopus 로고
    • Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
    • ZYGMUNT PM, PETERSSON J, ANDERSSON DA et al.: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (1999) 400(6743):452-457.
    • (1999) Nature , vol.400 , Issue.6743 , pp. 452-457
    • Zygmunt, P.M.1    Petersson, J.2    Andersson, D.A.3
  • 18
    • 0037216692 scopus 로고    scopus 로고
    • Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes
    • SOUTHALL MD, LI T, GHARIBOVA LS, PEI Y, NICOL GD, TRAVERS JB: Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J. Pharmacol. Exp. Ther. (2003) 304(1):217-222.
    • (2003) J. Pharmacol. Exp. Ther. , vol.304 , Issue.1 , pp. 217-222
    • Southall, M.D.1    Li, T.2    Gharibova, L.S.3    Pei, Y.4    Nicol, G.D.5    Travers, J.B.6
  • 19
    • 28844445067 scopus 로고    scopus 로고
    • Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems
    • ZHANG N, OPPENHEIM JJ: Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems. J. Leukoc. Biol. (2005) 78(6):1210-1214.
    • (2005) J. Leukoc. Biol. , vol.78 , Issue.6 , pp. 1210-1214
    • Zhang, N.1    Oppenheim, J.J.2
  • 20
    • 0033856751 scopus 로고    scopus 로고
    • Ajulemic acid (CT3): A potent analog of the acid metabolites of THC
    • BURSTEIN SH: Ajulemic acid (CT3): a potent analog of the acid metabolites of THC. Curr. Pharm. Des. (2000) 6(13):1339-1345.
    • (2000) Curr. Pharm. Des. , vol.6 , Issue.13 , pp. 1339-1345
    • Burstein, S.H.1
  • 21
    • 27644448758 scopus 로고    scopus 로고
    • Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials
    • BURSTEIN S: Ajulemic acid (IP-751): synthesis, proof of principle, toxicity studies, and clinical trials. AAPS J. (2005) 7(1):E143-E148.
    • (2005) AAPS J. , vol.7 , Issue.1
    • Burstein, S.1
  • 22
    • 23044475561 scopus 로고    scopus 로고
    • PPAR-gamma: A nuclear receptor with affinity for cannabinoids
    • BURSTEIN S: PPAR-gamma: a nuclear receptor with affinity for cannabinoids. Life Sci. (2005) 77(14):1674-1684.
    • (2005) Life Sci. , vol.77 , Issue.14 , pp. 1674-1684
    • Burstein, S.1
  • 23
    • 0141593561 scopus 로고    scopus 로고
    • Analgesic effecc of the synthetic cannabinoid CT-3 on chronic neuropathic pain: A randomized controlled trial
    • KARST M, SALIM K, BURSTEIN S, CONRAD I, HOY L, SCHNEIDER U: Analgesic effecc of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA (2003) 290(13):1757-1762.
    • (2003) JAMA , vol.290 , Issue.13 , pp. 1757-1762
    • Karst, M.1    Salim, K.2    Burstein, S.3    Conrad, I.4    Hoy, L.5    Schneider, U.6
  • 24
    • 0141677644 scopus 로고    scopus 로고
    • Short-term effects of cannabinoids in patients with HIV-1 infection: A randomized, placebo-controlled clinical trial
    • ABRAMS DI, HILTON JF, LEISER RJ et al.: Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann. Intern. Med. (2003) 139(4):258-66.
    • (2003) Ann. Intern. Med. , vol.139 , Issue.4 , pp. 258-266
    • Abrams, D.I.1    Hilton, J.F.2    Leiser, R.J.3
  • 25
    • 20444487825 scopus 로고    scopus 로고
    • Cannabinoid influence on cytokine profile in multiple sclerosis
    • KATONA S, KAMINSKI E, SANDERS H, ZAJICEK J: Cannabinoid influence on cytokine profile in multiple sclerosis. Clin. Exp. Immunol. (2005) 140(3):580-585.
    • (2005) Clin. Exp. Immunol. , vol.140 , Issue.3 , pp. 580-585
    • Katona, S.1    Kaminski, E.2    Sanders, H.3    Zajicek, J.4
  • 26
    • 0242654882 scopus 로고    scopus 로고
    • Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial
    • ZAJICEK J, FOX P, SANDERS H et al.: Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet (2003) 362(9395):1517-1526.
    • (2003) Lancet , vol.362 , Issue.9395 , pp. 1517-1526
    • Zajicek, J.1    Fox, P.2    Sanders, H.3
  • 27
    • 0038449770 scopus 로고    scopus 로고
    • NO AUTHORS LISTED: (58th edn), Thomson Healthcare, Montvale, New Jersey, USA
    • NO AUTHORS LISTED: Physicians Desk Reference (58th edn), Thomson Healthcare, Montvale, New Jersey, USA (2004):3241-3243
    • (2004) Physicians Desk Reference , pp. 3241-3243
  • 28
    • 33749242498 scopus 로고    scopus 로고
    • The development of Sativex® - A natural cannabis-based medicine
    • In: Mechoulam R (Ed.), Birkhauser Verlag, Basel, Boston, Berlin
    • GUY GW, STOUT CG: The development of Sativex® - a natural cannabis-based medicine. In: Cannabinoids as Therapeutics. Milestones in Drug Therapy. Mechoulam R (Ed.), Birkhauser Verlag, Basel, Boston, Berlin (2005):231-260.
    • (2005) Cannabinoids As Therapeutics. Milestones in Drug Therapy , pp. 231-260
    • Guy, G.W.1    Stout, C.G.2
  • 29
    • 2942585608 scopus 로고    scopus 로고
    • Chemokine blockade: A new era in the treatment of rheumatoid arthritis?
    • HARINGMAN JJ, TAK PP: Chemokine blockade: a new era in the treatment of rheumatoid arthritis? Arthritis Res. Ther. (2004) 6:93-97.
    • (2004) Arthritis Res. Ther. , vol.6 , pp. 93-97
    • Haringman, J.J.1    Tak, P.P.2
  • 32
    • 0032949907 scopus 로고    scopus 로고
    • 2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60
    • 2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60. FEBS Lett. (1999) 448(2-3):273-277.
    • (1999) FEBS Lett. , vol.448 , Issue.2-3 , pp. 273-277
    • Jbilo, O.1    Derocq, J.M.2    Segui, M.3    Le Fur, G.4    Casellas, P.5
  • 33
    • 0037089221 scopus 로고    scopus 로고
    • Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol
    • JORDA MA, VERBAKEL SE, VALK PJ et al.: Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood (2002) 99:2786-2793.
    • (2002) Blood , vol.99 , pp. 2786-2793
    • Jorda, M.A.1    Verbakel, S.E.2    Valk, P.J.3
  • 35
    • 7644244850 scopus 로고    scopus 로고
    • 2-Arachidonoylglycerol, an endogenoet al.: Us cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils
    • OKA S, IKEDA S, KISHIMOTO S et al.: 2-Arachidonoylglycerol, an endogenoet al.: us cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. J. Leukoc. Biol. (2004) 76(5):1002-1009.
    • (2004) J. Leukoc. Biol. , vol.76 , Issue.5 , pp. 1002-1009
    • Oka, S.1    Ikeda, S.2    Kishimoto, S.3
  • 37
  • 38
    • 10044257545 scopus 로고    scopus 로고
    • The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein
    • MAESTRONI GJM: The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein. FASEB J. (2004) 18(15):1914-1916.
    • (2004) FASEB J. , vol.18 , Issue.15 , pp. 1914-1916
    • Maestroni, G.J.M.1
  • 39
    • 25444464434 scopus 로고    scopus 로고
    • Involvement of cannabinoid CB(2) recepcor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice
    • UEDA Y, MIYAGAWA N, MATSUI T, KAYA T, IWAMURA H: Involvement of cannabinoid CB(2) recepcor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Eur. J. Pharmacol. (2005) 520(1-3):164-171.
    • (2005) Eur. J. Pharmacol. , vol.520 , Issue.1-3 , pp. 164-171
    • Ueda, Y.1    Miyagawa, N.2    Matsui, T.3    Kaya, T.4    Iwamura, H.5
  • 40
    • 12444290061 scopus 로고    scopus 로고
    • 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells
    • GOKOH M, KISHIMOTO S, OKA S et al.: 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells. Biochem. J. (2005) 386:583-589.
    • (2005) Biochem. J. , vol.386 , pp. 583-589
    • Gokoh, M.1    Kishimoto, S.2    Oka, S.3
  • 41
    • 33744948790 scopus 로고    scopus 로고
    • Effects of peripheral cannabionoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils
    • KURIHARA R, TOHYAMA Y, MATSUSAKA S et al.: Effects of peripheral cannabionoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils. J. Biol. Chem. (2006) 281:12908-12918.
    • (2006) J. Biol. Chem. , vol.281 , pp. 12908-12918
    • Kurihara, R.1    Tohyama, Y.2    Matsusaka, S.3
  • 43
    • 33745627474 scopus 로고    scopus 로고
    • Adenosine A2a receptors induce heterologous desensitization of chemokine receptors
    • ZHANG N, YANG D, DONG H et al.: Adenosine A2a receptors induce heterologous desensitization of chemokine receptors. Blood (2006) 108(1):38-44.
    • (2006) Blood , vol.108 , Issue.1 , pp. 38-44
    • Zhang, N.1    Yang, D.2    Dong, H.3
  • 45
    • 0041382826 scopus 로고    scopus 로고
    • Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10
    • FINE JS, ROJAS-TRIANA A, JACKSON JV et al.: Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10. Inflammation (2003) 27(4):161-174.
    • (2003) Inflammation , vol.27 , Issue.4 , pp. 161-174
    • Fine, J.S.1    Rojas-Triana, A.2    Jackson, J.V.3
  • 46
    • 0034594905 scopus 로고    scopus 로고
    • Cannabinoids control spasticity and tremor in a multiple sclerosis model
    • BAKER D, PRYCE G, CROXFORD JL et al.: Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature (2000) 404(6773):84-87.
    • (2000) Nature , vol.404 , Issue.6773 , pp. 84-87
    • Baker, D.1    Pryce, G.2    Croxford, J.L.3
  • 49
    • 16544377251 scopus 로고    scopus 로고
    • Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model
    • NI X, GELLER EB, EPPIHIMER MJ, EISENSTEIN TK, ADLER MW, TUMA RF: Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/ endothelial interactions in an experimental autoimmune encephalomyelitis model. Mult. Scler. (2004) 10:158-164.
    • (2004) Mult. Scler. , vol.10 , pp. 158-164
    • Ni, X.1    Geller, E.B.2    Eppihimer, M.J.3    Eisenstein, T.K.4    Adler, M.W.5    Tuma, R.F.6
  • 50
    • 22144477141 scopus 로고    scopus 로고
    • 2) receptor gene polymorphism: Possible risk for autoimmune disorders
    • 2) receptor gene polymorphism: possible risk for autoimmune disorders. J. Leukoc. Biol. (2005) 78(1):231-238.
    • (2005) J. Leukoc. Biol. , vol.78 , Issue.1 , pp. 231-238
    • Sipe, J.C.1    Arbour, N.2    Gerber, A.3    Beutler, E.4
  • 51
    • 33646596336 scopus 로고    scopus 로고
    • Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
    • WITTING A, CHEN L, CUDABACK E et al.: Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc. Natl. Acad. Sci. USA (2006) 103(16):6362-6367.
    • (2006) Proc. Natl. Acad. Sci. USA , vol.103 , Issue.16 , pp. 6362-6367
    • Witting, A.1    Chen, L.2    Cudaback, E.3
  • 52
    • 0036260089 scopus 로고    scopus 로고
    • Targeting leukocyte MMPs and transmigration: Minocycline as a potential therapy for multiple sclerosis
    • BRUNDULA V, REWCASTLE N, METZ LM, BERNARD C, YONG V: Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain (2002) 125(Pt 6):1297-308.
    • (2002) Brain , vol.125 , Issue.PART 6 , pp. 1297-1308
    • Brundula, V.1    Rewcastle, N.2    Metz, L.M.3    Bernard, C.4    Yong, V.5
  • 54
    • 0031732074 scopus 로고    scopus 로고
    • The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients
    • WOLFE F, HAWLEY DJ: The longterm outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. J. Rheumatol. (1998) 25:2108-2117.
    • (1998) J. Rheumatol. , vol.25 , pp. 2108-2117
    • Wolfe, F.1    Hawley, D.J.2
  • 57
    • 27944510259 scopus 로고    scopus 로고
    • Cannabinoid receptor type 2 gene is associated with human osteoporosis
    • KARSAK M, COHEN-SOLAL M, FREUDENBERG J et al.: Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum. Mol. Genet. (2005) 14:3389-3396.
    • (2005) Hum. Mol. Genet. , vol.14 , pp. 3389-3396
    • Karsak, M.1    Cohen-Solal, M.2    Freudenberg, J.3
  • 58
    • 24344509882 scopus 로고    scopus 로고
    • Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies
    • SHANKAR BB, LAVEY BJ, ZHOU G et al.: Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies. Bioorg. Med. Chem. Lett. (2005) 15(20):4417-4420.
    • (2005) Bioorg. Med. Chem. Lett. , vol.15 , Issue.20 , pp. 4417-4420
    • Shankar, B.B.1    Lavey, B.J.2    Zhou, G.3
  • 59
    • 22544439953 scopus 로고    scopus 로고
    • Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
    • IDRIS, AI, VAN'T HOF, RJ, GREIG, IR et al.: Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat. Med. (2005) 11:774-779.
    • (2005) Nat. Med. , vol.11 , pp. 774-779
    • Idris, A.I.1    Van't Hof, R.J.2    Greig, I.R.3
  • 60
    • 0038521050 scopus 로고    scopus 로고
    • Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation
    • NACKLEY AG, MAKRIYANNIS A, HOHMANN AG: Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience (2003) 119(3):747-757.
    • (2003) Neuroscience , vol.119 , Issue.3 , pp. 747-757
    • Nackley, A.G.1    Makriyannis, A.2    Hohmann, A.G.3
  • 62
    • 28544440521 scopus 로고    scopus 로고
    • 2 receptor agonist activity in the hindpaw incision model of postoperative pain
    • 2 receptor agonist activity in the hindpaw incision model of postoperative pain. Eur. J. Pharmacol. (2005) 527(1-3):172-174.
    • (2005) Eur. J. Pharmacol. , vol.527 , Issue.1-3 , pp. 172-174
    • Labuda, C.J.1    Koblish, M.2    Little, P.J.3
  • 63
    • 0033035659 scopus 로고    scopus 로고
    • SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist
    • PORTIER M, RINALDI-CARMONA M, PECCEU F et al.: SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. J. Pharmacol. Exp. Ther. (1999) 288(2):582-589.
    • (1999) J. Pharmacol. Exp. Ther. , vol.288 , Issue.2 , pp. 582-589
    • Portier, M.1    Rinaldi-Carmona, M.2    Pecceu, F.3
  • 64
    • 0033575258 scopus 로고    scopus 로고
    • 2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses
    • 2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses. J. Biol. Chem. (1999) 274(29):20397-20405.
    • (1999) J. Biol. Chem. , vol.274 , Issue.29 , pp. 20397-20405
    • Bouaboula, M.1    Dussossoy, D.2    Casellas, P.3
  • 65
    • 12744258068 scopus 로고    scopus 로고
    • Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage
    • MBVUNDULA EC, BUNNING RA, RAINSFORD KD: Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage. Biochem. Pharmacol. (2005) 69(4):635-640.
    • (2005) Biochem. Pharmacol. , vol.69 , Issue.4 , pp. 635-640
    • Mbvundula, E.C.1    Bunning, R.A.2    Rainsford, K.D.3
  • 69
    • 0141649387 scopus 로고    scopus 로고
    • Bradykinin antagonists as anti-cancer agents
    • STEWART JM: Bradykinin antagonists as anti-cancer agents. Curr. Pharm. Des. (2003) 9(25):2036-2042.
    • (2003) Curr. Pharm. Des. , vol.9 , Issue.25 , pp. 2036-2042
    • Stewart, J.M.1
  • 70
    • 18144422077 scopus 로고    scopus 로고
    • Theoxyrocin receptor antagonist arosiban inhibits cell growth via a 'biased agonist' mechanism
    • REVERSI A, RIMOLDI V, MARROCCO T et al.: Theoxyrocin receptor antagonist arosiban inhibits cell growth via a 'biased agonist' mechanism. J. Biol. Chem. (2005) 280(16):16311-16318.
    • (2005) J. Biol. Chem. , vol.280 , Issue.16 , pp. 16311-16318
    • Reversi, A.1    Rimoldi, V.2    Marrocco, T.3
  • 71
    • 20244366860 scopus 로고    scopus 로고
    • Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice
    • REICH EP, CUI L, YANG L et al.: Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice. Eur. J. Immunol. (2005) 35(4):1027-1036.
    • (2005) Eur. J. Immunol. , vol.35 , Issue.4 , pp. 1027-1036
    • Reich, E.P.1    Cui, L.2    Yang, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.